Why are urologists dismissive about Decipher?

Posted by topf @topf, 3 days ago

I have talked to four urologists. All four told me that the Decipher score does not change their assessment. On the other hand, the oncologist and the three radiologists I talked to all stressed it. Why is it perceived so differently?

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

As far as ADT use the Arterra AI platform is more instructive, Apparently 2/3 do not benefit from it as an add onto radiotherapy. 37% do benefit from its add on use. This test is predictive and prognostic. Decipher is based on a genomic platform that is prognostic.

I have read that the problem is the application of the score to historical data supplanted by newer metastatic risk technology assessment methods, e.g., dye enhanced multiparametric MRI (mpMRI) and PSMA PET/CT scanning. These two and the Decipher score may provide a more sanguine context to the previous
Gleason scoring only. Add to them the tumor size and or its changes over surveillance periods, and other criteria easily susceptible to new Artificial Intelligence derived algorithm correlations in the near future.

REPLY
@heavyphil

Most urologists are surgeons. They could care less about aggressiveness based on Decipher - they are cutting based on Gleason Score - PERIOD.
RO’s, however, used Decipher primarily to access whether ADT is necessary as part of their treatment. The higher the Decipher, the greater the need for weakening cells predisposed to metastasis. Remember, radiologists leave the gland IN, and if the PCa isn’t eradicated on the first go round, retreatment becomes more challenging. Hope this helps.
Phil

Jump to this post

heavyphil,
all prostate surgeons are urologists. There are urologist who also perform prostate surgery. There are many urological surgeries aside from prostatectomy. "Most urologists are"surgeons."
Most urologist are not Surgical Oncologists.
The Surgical Oncologist at USC, who did not perform surgery in this case, insisted on two months of ADT prior in order to reach the "sweet spot." Even though the surgery removes the entire prostate. The prostate bed remains with some risk of biological recurrence.

REPLY
@topf

The urologists also told me that Decipher was developed for liw risk patients to determine if they could go on AS. I understand that it dors not affect how surgery is conducted, but it seems they fon’t even think that it has an effect on overall prognosis.

Jump to this post

This doesn’t make any sense. The decipher test is used after cancer is found. It is not to determine whether or not active surveillance would work. The PSE test is something you use to figure out whether there is cancer there yet, and to pick AS and avoid a biopsy if it shows nothing.

I suppose if you had a person with only one or two Gleason 3+4 cores, A very low decipher could decide to go on active surveillance, But the test is More designed to figure out whether or not you’re going to have something come back soon after treatment.

REPLY
@bjroc

I think one of the problems is that decipher is just a partly open black box. Yes they publish some stuff, but it isn't like Mayo or some other place like NIH is saying all the genetic factors are exactly what decipher says after pouring over tons of data and looking at thousands of patients. It is a semi-closed, semi-open black box.

Jump to this post

That’s the nature of machine learning algorithms. They are black boxes. Sometimes they layer ‘reasoning’ over the results but that’s really not an accurate assessment of what actually goes on behind the scenes.

REPLY
@jeffmarc

This doesn’t make any sense. The decipher test is used after cancer is found. It is not to determine whether or not active surveillance would work. The PSE test is something you use to figure out whether there is cancer there yet, and to pick AS and avoid a biopsy if it shows nothing.

I suppose if you had a person with only one or two Gleason 3+4 cores, A very low decipher could decide to go on active surveillance, But the test is More designed to figure out whether or not you’re going to have something come back soon after treatment.

Jump to this post

Yes, several urologists told me exactly that. That decipher isused in 3+3 and 3+4 cases to decide on AS. I understand that with 4+4 it does not affect treatment decisions, but it should affect their assessment of recurrence risks.

REPLY
@vircet

In my understanding, only "medically necessary" procedures are covered by our taxpayer-funded medical care. I asked my oncologist about Decipher test. I was told it's done for high risk patients; It was indicated to me that I didn't need it because I wasn't high risk. I didn't argue with my oncologist.

Jump to this post

Two years ago my urologist/surgeon suggested the Decipher test after my 3rd biopsy. I hadn't heard about it at the time. It was covered by (Original) Medicare.

I wasn't high risk. 1st biopsy was one core 3+3, less then 5%. The 2nd biopsy found no cancer.

It's possible that some Medicare Advantage programs might deny you. If that's your case, you can always contest it. In general 80% of contested MA denials are eventually approved.

REPLY
@jeffmarc

This doesn’t make any sense. The decipher test is used after cancer is found. It is not to determine whether or not active surveillance would work. The PSE test is something you use to figure out whether there is cancer there yet, and to pick AS and avoid a biopsy if it shows nothing.

I suppose if you had a person with only one or two Gleason 3+4 cores, A very low decipher could decide to go on active surveillance, But the test is More designed to figure out whether or not you’re going to have something come back soon after treatment.

Jump to this post

I'm one of those persons. 1st biopsy was 3+3, 1 core, less than 5%. 2nd biopsy nothing. 3rd biopsy 3+4, 1 core, less than 5%.

My urologist/surgeon suggested sending the 3+4 in for the Decipher analysis. (And he's a bit on the aggressive side; i.e. he's suggested surgery a couple of times.)

Result, low risk so I'm still on Active Surveillance and plan to stay on it as long as I can.

REPLY
@gently

heavyphil,
all prostate surgeons are urologists. There are urologist who also perform prostate surgery. There are many urological surgeries aside from prostatectomy. "Most urologists are"surgeons."
Most urologist are not Surgical Oncologists.
The Surgical Oncologist at USC, who did not perform surgery in this case, insisted on two months of ADT prior in order to reach the "sweet spot." Even though the surgery removes the entire prostate. The prostate bed remains with some risk of biological recurrence.

Jump to this post

Hey gently, a bit confused by your reply; is this your treatment involving ADT? Someone else? Either way, surgery was employed as primary treatment, no?. Don’t see any mention of Decipher used to find the “sweet spot” you mention, although we’ve discussed the pros and cons of shrinking the gland prior to surgery.
Phil

REPLY
@mauk

Sorry, I dont agree with your doc- I am a 3+4 and my oncologist highly recommended it after reading up on it and talk other experts in the field, they ALL recommended going for it. As far as cost Decipher a policy, they will cover $395 of the total cost, and they also have a plan where they dish out more money. They were very good at putting my case with the insurance company, who eventually picked up the entire cost.

Hope it helps and good luck!!

Jump to this post

Gleason 3+4 is borderline (the lowest result they usually refer to as "cancer" these days) — that's where something like Decipher is most useful, as a sort-of tie-breaker vote for choosing between more or less intervention.

As @jeffmarc mentioned, once you're up to Gleason 8 or 9 ( or actually metastasised), there's no longer any doubt that the cancer is serious and needs major intervention, with or without a Decipher test.

REPLY
@breadmaker

Two years ago my urologist/surgeon suggested the Decipher test after my 3rd biopsy. I hadn't heard about it at the time. It was covered by (Original) Medicare.

I wasn't high risk. 1st biopsy was one core 3+3, less then 5%. The 2nd biopsy found no cancer.

It's possible that some Medicare Advantage programs might deny you. If that's your case, you can always contest it. In general 80% of contested MA denials are eventually approved.

Jump to this post

Thanks for your comment, @breadmaker . My biopsy was done in late January. My urologist in the regional hospital referred me to a Cancer Center medical oncologist and radiation oncologist. I was seen by both the MO and the RO in February but neither mentioned Decipher. When I chose SBRT in March, I asked the RO about Decipher. I now think that at that point, if the RO decided in favor of Decipher, it would have been difficult to obtain my two-month tissue samples from the regional hospital. Perhaps my urologist should have ordered Decipher as a soon as he got my pathology report Gleason 7 (3+4), positive on 8 of 14 cores. It was missed opportunity, I was advised to focus on choosing what treatment I like: open surgery, robotic-assisted radical prostatectomy, or SBRT. Two months passed by before I chose SBRT, that I completed on month 3 after my diagnosis. I hope this discussion will help newly-diagnosed members of this support group to ask about Decipher right away, or as soon as he is researching on the menu of treatment methods.

REPLY
Please sign in or register to post a reply.